Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Transcription Factor Repertoire of Homeostatic Eosinophilopoiesis.

Bouffi C, Kartashov AV, Schollaert KL, Chen X, Bacon WC, Weirauch MT, Barski A, Fulkerson PC.

J Immunol. 2015 Sep 15;195(6):2683-95. doi: 10.4049/jimmunol.1500510.

2.

IL-5 triggers a cooperative cytokine network that promotes eosinophil precursor maturation.

Fulkerson PC, Schollaert KL, Bouffi C, Rothenberg ME.

J Immunol. 2014 Oct 15;193(8):4043-52. doi: 10.4049/jimmunol.1400732.

3.

Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development.

Ben Baruch-Morgenstern N, Shik D, Moshkovits I, Itan M, Karo-Atar D, Bouffi C, Fulkerson PC, Rashkovan D, Jung S, Rothenberg ME, Munitz A.

Nat Immunol. 2014 Jan;15(1):36-44. doi: 10.1038/ni.2757.

4.

IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop.

Bouffi C, Rochman M, Zust CB, Stucke EM, Kartashov A, Fulkerson PC, Barski A, Rothenberg ME.

J Immunol. 2013 Oct 15;191(8):4317-25. doi: 10.4049/jimmunol.1301465.

5.

An autocrine neuronal interleukin-6 loop mediates chloride accumulation and NKCC1 phosphorylation in axotomized sensory neurons.

Pieraut S, Lucas O, Sangari S, Sar C, Boudes M, Bouffi C, Noel D, Scamps F.

J Neurosci. 2011 Sep 21;31(38):13516-26. doi: 10.1523/JNEUROSCI.3382-11.2011.

6.

Skin fibroblasts are potent suppressors of inflammation in experimental arthritis.

Bouffi C, Bony C, Jorgensen C, Noël D.

Ann Rheum Dis. 2011 Sep;70(9):1671-6. doi: 10.1136/ard.2010.143297.

PMID:
21623002
7.

IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis.

Bouffi C, Bony C, Courties G, Jorgensen C, Noël D.

PLoS One. 2010 Dec 7;5(12):e14247. doi: 10.1371/journal.pone.0014247.

8.

The role of pharmacologically active microcarriers releasing TGF-beta3 in cartilage formation in vivo by mesenchymal stem cells.

Bouffi C, Thomas O, Bony C, Giteau A, Venier-Julienne MC, Jorgensen C, Montero-Menei C, Noël D.

Biomaterials. 2010 Sep;31(25):6485-93. doi: 10.1016/j.biomaterials.2010.05.013.

PMID:
20570347
9.

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications.

Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noël D.

Stem Cell Res Ther. 2010 Mar 15;1(1):2. doi: 10.1186/scrt2.

10.

Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis.

Khoury M, Courties G, Fabre S, Bouffi C, Seemayer CA, Vervoordeldonk MJ, Tak PP, Jorgensen C, Apparailly F.

Arthritis Rheum. 2010 Mar;62(3):765-70. doi: 10.1002/art.27302.

11.

Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy.

Vinatier C, Bouffi C, Merceron C, Gordeladze J, Brondello JM, Jorgensen C, Weiss P, Guicheux J, Noël D.

Curr Stem Cell Res Ther. 2009 Dec;4(4):318-29. Review.

12.

Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.

Djouad F, Bouffi C, Ghannam S, Noël D, Jorgensen C.

Nat Rev Rheumatol. 2009 Jul;5(7):392-9. doi: 10.1038/nrrheum.2009.104. Review.

PMID:
19568253
13.

Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?

Bouffi C, Djouad F, Mathieu M, Noël D, Jorgensen C.

Rheumatology (Oxford). 2009 Oct;48(10):1185-9. doi: 10.1093/rheumatology/kep162. Review.

PMID:
19561159
14.

Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor.

Fritz V, Noël D, Bouquet C, Opolon P, Voide R, Apparailly F, Louis-Plence P, Bouffi C, Drissi H, Xie C, Perricaudet M, Müller R, Schwarz E, Jorgensen C.

Stem Cells. 2008 Nov;26(11):2981-90. doi: 10.1634/stemcells.2008-0139.

15.

Multipotent mesenchymal stromal cells in articular diseases.

Jorgensen C, Djouad F, Bouffi C, Mrugala D, Noël D.

Best Pract Res Clin Rheumatol. 2008 Apr;22(2):269-84. doi: 10.1016/j.berh.2008.01.005. Review.

PMID:
18455684
16.

Multipotent mesenchymal stromal cells and immune tolerance.

Noël D, Djouad F, Bouffi C, Mrugala D, Jorgensen C.

Leuk Lymphoma. 2007 Jul;48(7):1283-9. Review.

PMID:
17613755
17.

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism.

Djouad F, Charbonnier LM, Bouffi C, Louis-Plence P, Bony C, Apparailly F, Cantos C, Jorgensen C, Noël D.

Stem Cells. 2007 Aug;25(8):2025-32.

Supplemental Content

Loading ...
Support Center